Related Experiment Video
Updated: Aug 17, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
[Molecular indicators of neoplasia in clinical diagnostics]
Katarzyna Gawron1, Andrzej Wiczkowski, Brygida Adamek
1Katedra i Zakład Ogólnej Biologii Lekarskiej Slaskiej Akademii Medycznej w Zabrzu-Rokitnicy. ksr@silesianet.pl
Abstract:
In normal conditions growth and cell division processes in tissues and organs are precisely regulated. On the molecular level these processes demand coordination of protooncogenes, suppressor genes, mismatch repair system genes and apoptotic genes expression. Mutations presence leads to alteration or loss of their function. In the consequence of these lesions cumulation of DNA errors cumulation and loss of cellular proliferation control take place, what leads to genome instability and promotes selection of cells clone being able to hyper-proliferate. Mutations presence in mentioned above groups of genes in high percentage had been detecting in cells of neoplasms described in this review. According to clinical observations presence of mutations in these genes influenced on the clinical course and prognosis. The aim of this review was to focus on mutations found in protooncogenes, suppressor genes, mismatch repair system and apoptotic genes, which in development of some genetically determined neoplasms, some syndromes predisposing to neoplasm development and in some sporadic neoplasms in high percentage had been detected. The presence of mutations in mentioned above groups of genes as molecular neoplasias indicators' in clinical diagnostics had been taking into account.
Insights
Mutations in key genes like proto-oncogenes and tumor suppressors disrupt cell growth control, leading to genome instability and cancer. These genetic alterations are crucial indicators for neoplasm diagnosis and prognosis.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Context:
- Cellular growth and division are tightly regulated by genes including proto-oncogenes, suppressor genes, mismatch repair genes, and apoptotic genes.
- Disruptions in these genes, through mutations, lead to DNA errors and uncontrolled cell proliferation.
Purpose:
- To review mutations in proto-oncogenes, suppressor genes, mismatch repair system genes, and apoptotic genes.
- To highlight the role of these mutations in genetically determined, predisposition syndromes, and sporadic neoplasms.
- To emphasize their significance as molecular indicators in clinical diagnostics.
Summary:
- Mutations in critical gene groups (proto-oncogenes, suppressor, mismatch repair, apoptotic) disrupt normal cellular regulation.
- Accumulated DNA errors and loss of proliferation control result in genome instability and hyper-proliferation.
- These mutations are frequently detected in neoplasms and impact clinical course and prognosis.
Impact:
- Identifies key genetic markers for neoplasm development and progression.
- Provides insights into the molecular basis of genetically determined and sporadic cancers.
- Supports the use of these genetic mutations as diagnostic and prognostic indicators in clinical settings.
